These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy of bendamustine in rituximab-refractory indolent B-cell non-Hodgkin lymphoma: review of a pivotal trial. Ujjani C; Cheson B Future Oncol; 2011 Jan; 7(1):9-14. PubMed ID: 21174533 [TBL] [Abstract][Full Text] [Related]
23. Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab-bendamustine. García-Muñoz R; García DK; Roldán-Galiacho V; Merchante-Andreu M; Campeny-Najara A; Rabasa P Ann Hematol; 2014 Apr; 93(4):699-702. PubMed ID: 23907409 [No Abstract] [Full Text] [Related]
24. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia. Kath R; Blumenstengel K; Fricke HJ; Höffken K J Cancer Res Clin Oncol; 2001 Jan; 127(1):48-54. PubMed ID: 11206271 [TBL] [Abstract][Full Text] [Related]
25. Bendamustine: new perspective for an old drug in lymphoproliferative disorders. Montillo M; Ricci F; Tedeschi A; Vismara E; Morra E Expert Rev Hematol; 2010 Apr; 3(2):131-48. PubMed ID: 21083456 [TBL] [Abstract][Full Text] [Related]
27. Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patients. Ghesquières H; Stamatoullas A; Casasnovas O; Morschhauser F; Gyan E; Gabarre J; Malphettes M; Clément L; Ferlay C; Brice P Leuk Lymphoma; 2013 Nov; 54(11):2399-404. PubMed ID: 23410099 [TBL] [Abstract][Full Text] [Related]
28. Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009. Schmidt C; Fingerle-Rowson G; Boehme A; Brendel K; Fischer R; Gonnermann M; Höhler T; Kegel T; Kellermann L; Nusch A; Pönisch W; Wendtner C; Dreyling M Leuk Lymphoma; 2015 Mar; 56(3):694-702. PubMed ID: 24937122 [TBL] [Abstract][Full Text] [Related]
29. Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience. Moore L; Bartels T; Persky DO; Abraham I; Kumar A; McBride A Support Care Cancer; 2021 Aug; 29(8):4867-4874. PubMed ID: 33547525 [TBL] [Abstract][Full Text] [Related]
30. Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemia. Goldschmidt N; Gural A; Ben-Yehuda D; Gatt ME Cancer Chemother Pharmacol; 2013 Sep; 72(3):709-13. PubMed ID: 23907444 [TBL] [Abstract][Full Text] [Related]
31. Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma. Gil L; Kazmierczak M; Kroll-Balcerzak R; Komarnicki M Med Oncol; 2014 May; 31(5):944. PubMed ID: 24752517 [TBL] [Abstract][Full Text] [Related]
32. Bendamustine: a review of its use in the management of indolent non-Hodgkin lymphoma. Plosker GL; Carter NJ Drugs; 2008; 68(18):2645-60. PubMed ID: 19093705 [TBL] [Abstract][Full Text] [Related]